Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Norgren

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Current Vascular Pharmacology|June 25, 2010
ESVS Guidelines: Section A--prevention in patients with carotid stenosisChristos D Liapis, Peter F Bell, Dimitri P Mikhailidis, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 9, 2002
Salvage of an acutely ruptured thoracic aortic aneurysm during CPRThomas Larzon, Håkan Jansson, Björn Holmström, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 13, 2010
The "no-touch" harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorumMats Dreifaldt, Domingos S R Souza, Andrzej Loesch, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 29, 2019
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE TrialLars Norgren, Norbert Weiss, Sigrid Nikol, et al.
Journal of the American College of Cardiology|April 28, 2022
Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery DiseaseSean A Behan, Hillary Mulder, Frank W Rockhold, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Circulation|June 21, 2017
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) InitiativeConnie N Hess, Lars Norgren, Gary M Ansel, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Circulation. Cardiovascular Interventions|October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID TrialAman Kansal, Zhen Huang, Frank W Rockhold, et al.
American Heart Journal|May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trialJeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Current Vascular Pharmacology|June 25, 2010
ESVS Guidelines: Section A--prevention in patients with carotid stenosisChristos D Liapis, Peter F Bell, Dimitri P Mikhailidis, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 9, 2002
Salvage of an acutely ruptured thoracic aortic aneurysm during CPRThomas Larzon, Håkan Jansson, Björn Holmström, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 13, 2010
The "no-touch" harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorumMats Dreifaldt, Domingos S R Souza, Andrzej Loesch, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 29, 2019
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE TrialLars Norgren, Norbert Weiss, Sigrid Nikol, et al.
Journal of the American College of Cardiology|April 28, 2022
Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery DiseaseSean A Behan, Hillary Mulder, Frank W Rockhold, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Circulation|June 21, 2017
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) InitiativeConnie N Hess, Lars Norgren, Gary M Ansel, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
Circulation. Cardiovascular Interventions|October 5, 2019
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID TrialAman Kansal, Zhen Huang, Frank W Rockhold, et al.
American Heart Journal|May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trialJeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
Pageof 8